Furthermore, we found that c-Myc overexpression significantly upregulated both USP22 promoter-driven luciferase activity (Fig. 3B) and USP22 protein levels in two lung cancer cells (A549, H1299) and a colorectal cancer cell line HCT116 (Fig. 3C). This evidence concerns the gene MYC and lung carcinoma.